Page last updated: 2024-11-02

4-phenylbutyric acid and Lipodystrophy

4-phenylbutyric acid has been researched along with Lipodystrophy in 1 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guridi, M1
Tintignac, LA1
Lin, S1
Kupr, B1
Castets, P1
Rüegg, MA1

Other Studies

1 other study available for 4-phenylbutyric acid and Lipodystrophy

ArticleYear
Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21.
    Science signaling, 2015, Nov-10, Volume: 8, Issue:402

    Topics: Animals; Endoplasmic Reticulum Stress; Fatty Acids; Female; Fibroblast Growth Factors; Glucose; Insu

2015